Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine ear drops for pain relief in children with acute otitis media
NL-OMON23221Not yet recruiting
- Sponsor
- Julius Center for Health Sciences and Primary Care
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of lidocaine in acute otitis media (AOM), sponsored by Julius Center for Health Sciences and Primary Care. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NL-OMON23221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23221.